ROBEAUTE

Summary

About

About ROBEAUTE

Robeauté's Dot device combines a micro-engine, flexible propeller, steering and tracking units, and interchangeable cargo on a thin tether. It is being designed to follow curved paths through brain tissue and take samples from multiple locations. Biopsy is the first intended application, with local drug delivery and electrode functions also under development.

The wider platform includes CAP, a launcher for deploying and retrieving Dot, and MOM, a console combining imaging, planning and navigation. These components connect the microrobot's position and measurements with the surgeon's view. The platform is investigational: it has neither FDA clearance nor CE marking and is unavailable for clinical use or commercial sale.

PRICE
Range 1Y
Return
High
Low
Updated

Funding

Investors

  • Brainlab - Participant - Unknown - 1 funding event - first seen 2025-01-13
  • Cherry Ventures - Participant - VC - 1 funding event - first seen 2025-01-13
  • Plural - Participant - Unknown - 1 funding event - first seen 2025-01-13

Timeline

Events

Context

Comparable profiles

Shared workflows

Context tags

  • Robot-assisted procedure workflow - Workflow - Reviewed July 15, 2026 against the company overview and structured profile evidence: surgical robotics companies.
  • Neurosurgical robotics - Workflow - Reviewed July 15, 2026 against the company overview and structured profile evidence: neurosurgical robotics.
  • Medical robot OEM - Stack Layer - Reviewed July 15, 2026 against the company overview and structured profile evidence: medical robot oem.